Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders

Completed · Phase 2

Conditions studied: Psychotic Disorders, Schizophrenia, Schizoaffective Disorder, Bipolar Disorder

In brief

This study evaluates the feasibility of administering meclofenamic acid or pentosan polysulfate sodium as an adjunctive treatment to patients diagnosed with a psychotic disorder. Half of participants will receive meclofenamic acid, while the other half will receive polysulfate sodium.

Key facts

Study ID
NCT02930005
Run by
The University of Texas Health Science Center, Houston
People needed
8
Starts
2015-08-07
Expected to finish
2016-10-06
Last updated by the study team
2019-03-26

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.